Related Experiment Video
Updated: May 12, 2026

High-throughput Identification of Synergistic Drug Combinations by the Overlap2 Method
Published on: May 21, 2018
Methods2AOP: A Collaboration to Strengthen the Integration of Test Methods into the Adverse Outcome Pathway Framework
Agnes L Karmaus1, William Bisson1, Albert Braeuning2
1Inotiv, Research Triangle Park, USA.
The Methods2AOP collaboration standardizes test method integration into the Adverse Outcome Pathway (AOP) framework. This enhances regulatory decision-making and promotes the adoption of New Approach Methods (NAMs).
Area of Science:
- Toxicology
- Regulatory Science
- Computational Biology
Background:
- The Adverse Outcome Pathway (AOP) framework organizes mechanistic toxicology data for regulatory assessment.
- Current integration of test method information, especially New Approach Methods (NAMs), into the AOP-Wiki is suboptimal.
- This limits the AOP framework's utility in regulatory decision-making.
Purpose of the Study:
- To review the work of the Methods2AOP collaboration in addressing the gap of test method integration within the AOP framework.
- To propose methods for enhancing the role and inclusion of test data within the AOP knowledgebase.
- To facilitate the regulatory acceptance and adoption of NAMs.
Main Methods:
- Review of the Methods2AOP collaboration's initiatives and outputs.
- Conceptual proposal for integrating structured test method information into the AOP knowledgebase.
- Utilizing ontologies for standardization and structuring of information.
Main Results:
- The Methods2AOP collaboration emphasizes linking detailed test method information to the AOP framework.
- A conceptual model demonstrates similarities between key event components and structured methods information.
- Proposed use of ontologies to standardize information, enhancing interoperability and reusability.
Conclusions:
- Implementing Methods2AOP recommendations will increase clarity and transparency of test method descriptions.
- This standardization supports regulatory acceptance and wider adoption of NAMs.
- The effort fosters a more robust and transparent AOP system aligned with scientific and regulatory goals.
Related Concept Videos
Methods of Documentation VI: Case Management Model
For example, a patient with a chronic illness...
Measurement of Bioavailability: Pharmacodynamic Methods
Methods of Documentation II: POMR
Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Therapeutic Drug Monitoring: Drug Analysis Methods
